Amicus Therapeutics (FOLD)

Amicus (FOLD) Income Statement


Amicus Income Statement

Last quarter (Q2 2023), Amicus's total revenue was $94.50M, an increase of 17.06% from the same quarter last year. In Q2, Amicus's net income was $-43.23M. See Amicus’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 350.56M$ 329.23M$ 305.51M$ 260.89M$ 182.24M$ 91.25M
Cost of Revenue
$ 6.22M$ -38.60M$ 34.47M$ 31.04M$ 21.96M$ 14.40M
Gross Profit
$ 311.68M$ 290.63M$ 271.05M$ 229.84M$ 160.27M$ 76.84M
Operating Expense
$ -33.70M$ -502.75M$ 470.97M$ 473.70M$ 461.01M$ 402.32M
Operating Income
$ 118.52M$ -204.43M$ -199.92M$ -243.85M$ -300.74M$ -325.48M
Net Non Operating Interest Income Expense
$ -38.58M$ -34.09M$ -31.96M$ -19.20M$ -8.62M$ -11.94M
Other Income Expense
$ 50.20M$ -3.10M$ -9.67M$ -11.20M$ -46.55M$ -11.67M
Pretax Income
$ -193.08M$ -242.04M$ -241.55M$ -274.25M$ -355.91M$ -349.09M
Tax Provision
$ -7.76M$ -5.47M$ 8.91M$ 2.60M$ 478.00K$ -94.00K
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ 62.50M$ -236.55M$ -250.46M$ -276.85M$ -356.39M$ -349.00M
Basic EPS
$ -0.64$ -0.82$ -0.92$ -1.07$ -1.48$ -1.88
Diluted EPS
$ -0.64$ -0.82$ -0.92$ -1.07$ -1.48$ -1.88
Basic Average Shares
$ 1.16B$ 289.06M$ 271.42M$ 258.87M$ 240.42M$ 185.79M
Diluted Average Shares
$ 1.16B$ 289.06M$ 271.42M$ 258.87M$ 240.42M$ 185.79M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ -27.47M$ -541.35M$ 505.43M$ 504.74M$ 482.98M$ 416.72M
Net Income From Continuing And Discontinued Operation
$ -185.31M$ -236.55M$ -250.46M$ -276.85M$ -356.39M$ -349.00M
Normalized Income
$ -63.82M-$ -245.52M$ -269.25M$ -353.98M$ -342.96M
Interest Expense
$ 9.62M-$ 32.47M$ 22.43M$ 18.87M$ 22.40M
$ -140.41M$ -239.37M$ -209.08M$ -251.83M$ -337.04M$ -326.69M
$ -136.17M$ -231.39M$ -202.87M$ -242.98M$ -332.26M$ -322.47M
Currency in USD

Amicus Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis